the discovery and development of liraglutide and semaglutide Frontiers Semaglutide as a GLP-1 Agonist:

Along with reduced appetite, users often feel more energized and focused, making it easier to maintain an active lifestyle and reach their weight loss goals. The FDA approved phentermine in adults aged 17 and older, typically for those with a BMI of 30 or higher, or 27 or higher with weight-related conditions

By introducing a drug like semaglutide to your body, youre asking it to adjust to a significant hormonal shift in how it processes food and regulates appetite

That equation has now changed dramatically

This neurological impact can help patients maintain their weight loss over time, making Semaglutide not just a short-term solution but a potential long-term strategy for managing obesity in conjunction with diabetes